16 active trials 12 recruiting 9 Phase 3 7 disease areas 1 changes in 30 days
| Phase 1/2 | 1 | |
| Phase 2 | 4 | |
| Phase 2/3 | 3 | |
| Phase 3 | 6 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT05518383 | B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 | Non-hodgkin Lymphoma,B Cell | Recruiting | 2022-08-26 |
| Phase 3 | ||||
| NCT07375563 | Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With… | Neuroblastoma (NB) | Recruiting | 2026-01-29 |
| NCT07232134 | The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in… | AML (Acute Myelogenous Leukemia) | Recruiting | 2025-11-20 |
| NCT05029531 | Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia… | Acute Lymphoblastic Leukemia, Pediatric | Recruiting | 2024-06-28 |
| NCT06071897 | Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma | Neuroblastoma | Recruiting | 2023-10-10 |
| NCT05549167 | Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal… | Juvenile Nasopharyngeal Angiofibroma | Recruiting | 2022-09-22 |
| NCT05515029 | Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and… | Acute Lymphoblastic Leukemia | Active, Not Recruiting | 2023-09-28 |
| Phase 2/3 | ||||
| NCT07366801 | Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell… | Acute Myeloid Leukemia, Relapsed | Recruiting | 2026-01-26 |
| NCT06756152 | Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and… | Biphenotypic Acute Leukemia | Recruiting | 2025-01-01 |
| NCT06475820 | Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and… | Acute Lymphoblastic Leukemia | Active, Not Recruiting | 2024-08-23 |
| Phase 2 | ||||
| NCT07256210 | Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse… | Acute Myeloid Leukemia | Recruiting | 2025-12-01 |
| NCT06198842 | Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage… | Nijmegen Breakage Syndrome | Recruiting | 2024-01-10 |
| NCT06199427 | PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in… | Inborn Errors of Immunity | Recruiting | 2024-01-10 |
| NCT07316595 | Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome | HSCT | Not Yet Recruiting | 2026-01-05 |
| Phase 1/2 | ||||
| NCT04499573 | Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL | B-ALL | Active, Not Recruiting | 2023-02-22 |
| Not specified | ||||
| NCT06296732 | Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification | Neuroblastoma | Recruiting | 2024-05-20 |
Acute Lymphoblastic Leukemia (ALL) (7) · Leukemia (7) · Acute Myeloid Leukemia (AML) (6) · Myelodysplastic Syndromes (MDS) (3) · Non-Hodgkin Lymphoma (2) · DLBCL (1) · MDS/MPN Overlap (1)